FDA indications According to the Prescribing Information, the wording of the FDA indications for semaglutide injection (Wegovy ) is as follows (the emphasis below in red has been added by us): WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight
, benzot sodn), barviva (karamel, tartrazin**).**tartrazin: me mt kodliv vliv na aktivitu a pozornost dt
L-carnitine may also potentiate the effect of oral anticoagulants such as warfarin
Overall impact on social life "I feel like my relationship with my husband is stronger than ever," said Melissa, "With my focus not being on food, I am more apt to gather with family and friends without worrying about what Im going to eat or what my next meal will be." - Melissa Daniella remarked that increased mood has allowed for more social interactions, which in turn strengthens those relationships and helps her feel more socially connected
discloses consultancy with Cambridge Cognition and receives research grants from Shionogi inc and Sirgartan
